DFDA

Mirtazapine

Treatment for Amphetamine Use Disorders

Typical Dosage: 30-45mg daily

Effectiveness
35%
Safety Score
60%
Clinical Trials
8
Participants
700

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
60
DangerousModerateSafe
Treatment Details
Dosage Range
30-45mg daily
Time to Effect
2-4 weeks
Treatment Duration
12-24 weeks
Evidence Quality
LOW
Confidence Score
50%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$200
Monitoring:$200
Side Effect Mgmt:$75
Total Annual:$475
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
POOR
QALYs Gained
0.05
Outcome-Based Costs
Cost per Responder
$1,583
Cost per Remission
$4,750
Mirtazapine Outcomes

for Amphetamine Use Disorders

Efficacy Outcomes
Overall Effectiveness
+35%
Response Rate
+30%
Remission Rate
+10%
Common Side Effects
Sedation/Drowsiness
+30%
Increased appetite/Weight gain
+18%
Dry mouth
+15%
Dizziness
+10%

Sources:

bu.edu
researchgate.net
nih.gov

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov